Neimeth International Pharmaceuticals Plc has stressed the urgent need for patient capital to drive sustainable growth in the pharmaceutical sector.
The company argued that high bank lending rates remain a major obstacle, limiting access to affordable financing for business expansion.
Patient capital is equity or debt that is invested to capture long-term benefits. With patient capital, the investor is willing to make a financial investment in a business with no expectation of turning a quick profit
Speaking at a Media Parley in Lagos, yesterday, the Managing Director of the company, Valentine Chinedu Okelu, pointed out that pharmaceutical manufacturing is capital-intensive, requiring long-term funding instead of short-term credits.
Therefore, he urged the government and high-net-worth individuals to inject patient capital to support the sector’s stability and expansion.
Beyond financial…
Read More
